The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Harrington Rare Disease Scholar Award Program sponsored by Takeda
The Harrington Rare Disease Scholar Award was created to advance breakthrough research into novel treatments for rare diseases. The Harrington Rare Disease Scholar Program is sponsored by Takeda Pharmaceutical Company Limited and overseen by Harrington Discovery Institute.
The Harrington Rare Disease Scholar Program will provide funding and hands-on drug development guidance for two years to U.S.-based MD and PhD researchers whose discoveries show promise for translation into novel medicines for rare diseases.
- Required Letter of Intent: July 19, 2017
- Full Application: October 4, 2017
Areas of Interest
Our current target areas of interest include all rare diseases, but of particular interest are rare diseases in the areas of neurology and gastroenterology. Projects in the area of rare cancers will be considered on a case-by-case basis.
• Academic investigators on faculty at accredited medical centers, research institutions, and universities in the United States only • Lead investigator must have an MD and/or PhD (or equivalent) • Past recipients of Harrington Scholar awards may submit new and distinct proposals, but may not seek additional support for previously funded projects
$150,000 guaranteed; potential award of up to $1,000,000